# SANDRIL
> **NDA009376** · New Drug Application · Sponsor: LILLY
## Drug
- **FDA Application Number:** NDA009376
- **Application type:** New Drug Application
- **Brand name:** SANDRIL
- **Generic name:** Reserpine
- **Active ingredients:** RESERPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LILLY
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009376)
---
*MORVS · CC0 1.0*